Fig. 3

Comparison of individual pCR and non-pCR patients. a Cell surface GRP78 expression in PBMC subpopulations in each patient after the taxane phase (P3) comparing patients who achieved pCR with non-pCR patients. b Representative FACS data dot blot of one pCR patient showing the FMO control for each PBMC subpopulation at the baseline (P1), after AC treatment (P2), and after taxanes treatment (P3)